As much as my compassionate side is siding with hospitals and patients, the company should be allowed to charge any price it considers reasonable for its product. Also I didn't like the inconspicuous ad hominem attacks on the supply-side players. The side-effect is that it leads the reader away from a subtle observation that the fair market controls to prevent these policies are simply missing and regulators have done little if nothing to prevent it. For instance, what does it mean 'controlled' distribution? Why is it difficult for the FDA to maintain reference formulas and manufacturing blueprints for all approved drugs past their patent-expiration date?